PDF herunterladen
J Pediatr Genet 2021; 10(03): 213-221
DOI: 10.1055/s-0040-1715528
Original Article

Clinical Characteristics, Molecular Profile, and Outcomes in Indian Patients with Glutaric Aciduria Type 1

Parag M. Tamhankar
1   Genetic Research Center, National Institute for Research in Reproductive Health, Mumbai, Maharashtra, India
2   Centre for Medical Genetics, Mumbai, Maharashtra, India
3   Sandor Life Sciences Pvt. Ltd., Hyderabad, Andhra Pradesh, India
,
Lakshmi Vasudevan
1   Genetic Research Center, National Institute for Research in Reproductive Health, Mumbai, Maharashtra, India
,
Pratima Kondurkar
1   Genetic Research Center, National Institute for Research in Reproductive Health, Mumbai, Maharashtra, India
,
Sarfaraj Niazi 
4   Biomedical Informatics Center of Indian Council of Medical Research, National Institute for Research in Reproductive Health, Mumbai, Maharashtra, India
,
Rita Christopher
5   Department of Neurochemistry, National Institute of Mental Health and Neuro Sciences, Bangalore, Karnataka, India
,
Dhaval Solanki
6   Mantra Child and Neurology and Epilepsy Clinic, Bhavnagar, Gujarat, India
,
Pooja Dholakia
7   Government Medical College, Bhavnagar, Gujarat, India
,
Mamta Muranjan 
8   Department of Pediatrics, Seth Gordhandas Sunderdas Medical College and King Edward Memorial hospital, Mumbai, Maharashtra, India
,
Mahesh Kamate
9   Department of Pediatric Neurology, Jawaharlal Nehru Medical College, Karnataka Lingayat Education University, Belgaum, Karnataka, India
,
Umesh Kalane
10   Pediatric Neurology Centre, Swargate, Pune, Maharashtra, India
,
Jayesh Sheth 
11   Foundation for Research in Genetics and Endocrinology Institute of Human Genetics, Foundation for Research in Genetics and Endocrinology House, Satellite, Ahmedabad, Gujarat, India
,
Vasundhara Tamhankar
2   Centre for Medical Genetics, Mumbai, Maharashtra, India
,
Reena Gulati
12   Department of Pediatrics, Jawaharlal Institute of Postgraduate Medical Education and Research, Gorimedu, Puducherry, India
,
Madhavi Vasikarla 
13   Fernandez Hospital, Hyderabad, Telengana, India
,
Sumita Danda 
14   Department of Medical Genetics, Christian Medical College, Vellore, Tamil Nadu, India
,
Shaik M. Naushad
3   Sandor Life Sciences Pvt. Ltd., Hyderabad, Andhra Pradesh, India
,
Katta M. Girisha
15   Department of Medical Genetics, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India
,
Shekhar Patil
16   Apollo Hospital, Navi Mumbai, Maharashtra, India
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Glutaric acidemia type 1 (GA-1, OMIM 231670) is an autosomal recessive inborn error of metabolism caused by the deficiency of glutaryl-coenzyme A (CoA) dehydrogenase with most children presenting in infancy with encephalopathy, dystonia, and macrocephaly. In this article, we presented the clinical characteristics, molecular profile, and outcomes in 29 unrelated families with affected children (30 cases total). The mean age at onset of illness was 10 months (±14.58), whereas the mean age at referral for molecular diagnosis was 29.44 months (±28.11). Patients were residents of nine different states of India. Clinical presentation varied from acute encephalitis followed by neuroregression and chronic/insidious developmental delay. Neurological sequelae varied from asymptomatic (no sequelae, 2 patients) to moderate (5 patients) and severe (23 patients) sequelae. All patients underwent blood tandem mass spectrometry (TMS on dried blood spots) and/or urine gas chromatography mass spectrometry (GCMS). Neuroimaging demonstrated batwing appearance in 95% cases. Sanger's sequencing of GCDH, covering all exons and exon–intron boundaries, was performed for all patients. Variants identified include 15 novel coding variants: p.Met100Thr, p.Gly107Ser, p.Leu179Val, p.Pro217Ser, p. Phe236Leufs*107, p.Ser255Pro, p.Met266Leufs*2, p.Gln330Ter, p.Thr344Ile, p.Leu345Pro, p.Lys377Arg, p.Leu424Pro, p.Asn373Lys, p.Lys377Arg, p.Asn392Metfs*9, and nine known genetic variants such as p.Arg128Gln, p.Leu179Arg, p.Trp225Ter, p.Met339Val, p.Gly354Ser, p.Arg402Gln, p.Arg402Trp, p.His403Tyr, and p.Ala433Val (Ensembl transcript ID: ENST00000222214). Using in silico analysis, genetic variants were shown to be affecting the residues responsible for homotetramer formation of the glutaryl-CoA dehydrogenase protein. Treatment included oral carnitine, riboflavin, protein-restricted diet, lysine-deficient special formulae, and management of acute crises with intravenous glucose and hydration. However, the mortality (9/30, 27.58%) and morbidity was high in our cohort with only two patients affording the diet. Our study is the largest multicentric, genetic variant–proven series of glutaric aciduria type 1 from India till date.

Keywords

glutaric aciduria - GCDH - novel - variant - in silico

Supplementary Material



Publikationsverlauf

Eingereicht: 06. Mai 2020

Angenommen: 27. Juni 2020

Artikel online veröffentlicht:
02. September 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Fu Z, Wang M, Paschke R, Rao KS, Frerman FE, Kim JJ. Crystal structures of human glutaryl-CoA dehydrogenase with and without an alternate substrate: structural bases of dehydrogenation and decarboxylation reactions. Biochemistry 2004; 43 (30) 9674-9684
    CrossrefPubMedGoogle Scholar
  • 2 Boy N, Mühlhausen C, Maier EM. et al; Additional individual contributors. Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision. J Inherit Metab Dis 2017; 40 (01) 75-101
    CrossrefPubMedGoogle Scholar
  • 3 Altschul SF, Madden TL, Schäffer AA. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25 (17) 3389-3402
    CrossrefPubMedGoogle Scholar
  • 4 Kleinberger J, Maloney KA, Pollin TI, Jeng LJ. An openly available online tool for implementing the ACMG/AMP standards and guidelines for the interpretation of sequence variants. Genet Med 2016; 18 (11) 1165
    CrossrefPubMedGoogle Scholar
  • 5 Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res 2012; 40 (Web Server issue): W452-7
    PubMedGoogle Scholar
  • 6 Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet 2013; 7: Unit7.20 . Doi: 10.1002/0471142905.hg0720s76
    PubMedGoogle Scholar
  • 7 Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 2010; 7 (08) 575-576
    CrossrefPubMedGoogle Scholar
  • 8 Reva B, Antipin Y, Sander C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res 2011; 39 (17) e118
    CrossrefPubMedGoogle Scholar
  • 9 Yue P, Melamud E, Moult J. SNPs3D: candidate gene and SNP selection for association studies. BMC Bioinformatics 2006; 7: 166
    CrossrefPubMedGoogle Scholar
  • 10 Venselaar H, Te Beek TA, Kuipers RK, Hekkelman ML, Vriend G. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinformatics 2010; 11: 548
    CrossrefPubMedGoogle Scholar
  • 11 Discovery Studio Modeling Environment, Release 4.5. 2015. BIOVIA, Dassault Systèmes, San Diego
  • 12 Tina KG, Bhadra R, Srinivasan N. PIC: protein interactions calculator. Nucleic Acids Res 2007;35(Web Server issue): W473-6. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436848/
    Google Scholar
  • 13 DeLano WL. The PyMOL Molecular Graphics System, San Carlos. Accessed July 19, 2020 at: https://www.scirp.org/(S(vtj3fa45qm1ean45vvffcz55))/reference/ReferencesPapers.aspx?ReferenceID=1958992
    Google Scholar
  • 14 Nair MKC, George B, Philip E, Lekshmi MA, Haran JC, Sathy N. Trivandrum developmental screening chart. Indian Pediatr 1991; 28 (08) 869-872
    PubMedGoogle Scholar
  • 15 Kamat VV. Measuring Intelligence of Indian Children. 4th ed. London, United Kingdom: Oxford University Press; 1968
    Google Scholar
  • 16 Kurkina MV, Mihaylova SV, Baydakova GV. et al. Molecular and biochemical study of glutaric aciduria type 1 in 49 Russian families: nine novel mutations in the GCDH gene. Metab Brain Dis 2020; 35 (06) 1009-1016
    CrossrefPubMedGoogle Scholar
  • 17 Westover JB, Goodman SI, Frerman FE. Pathogenic mutations in the carboxyl-terminal domain of glutaryl-CoA dehydrogenase: effects on catalytic activity and the stability of the tetramer. Mol Genet Metab 2003; 79 (04) 245-256
    CrossrefPubMedGoogle Scholar
  • 18 Rao KS, Albro M, Zirrolli JA, Vander Velde D, Jones DN, Frerman FE. Protonation of crotonyl-CoA dienolate by human glutaryl-CoA dehydrogenase occurs by solvent-derived protons. Biochemistry 2005; 44 (42) 13932-13940
    CrossrefPubMedGoogle Scholar
  • 19 Mushimoto Y, Fukuda S, Hasegawa Y. et al. Clinical and molecular investigation of 19 Japanese cases of glutaric acidemia type 1. Mol Genet Metab 2011; 102 (03) 343-348
    CrossrefPubMedGoogle Scholar
  • 20 Zayed H, El Khayat H, Tomoum H. et al. Clinical, biochemical, neuroradiological and molecular characterization of Egyptian patients with glutaric acidemia type 1. Metab Brain Dis 2019; 34 (04) 1231-1241
    CrossrefPubMedGoogle Scholar
  • 21 Gupta N, Singh PK, Kumar M. et al. Glutaric acidemia type 1-clinico-molecular profile and novel mutations in GCDH gene in indian patients. JIMD Rep 2015; 21: 45-55
    CrossrefPubMedGoogle Scholar
  • 22 Radha Rama Devi A, Ramesh VA, Nagarajaram HA, Satish SP, Jayanthi U, Lingappa L. Spectrum of mutations in glutaryl-CoA dehydrogenase gene in glutaric aciduria type I--study from South India. Brain Dev 2016; 38 (01) 54-60
    CrossrefPubMedGoogle Scholar
  • 23 Tp KV, Muntaj S, Devaraju KS, Kamate M, Vedamurthy AB. Genetic screening of selected disease-causing mutations in glutaryl-CoA dehydrogenase gene among Indian patients with glutaric aciduria type I. J Pediatr Genet 2017; 6 (03) 142-148
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 24 Guerreiro G, Faverzani J, Jacques CED. et al. Oxidative damage in glutaric aciduria type I patients and the protective effects of l-carnitine treatment. J Cell Biochem 2018; 119 (12) 10021-10032
    CrossrefPubMedGoogle Scholar
  • 25 Bishop FS, Liu JK, McCall TD, Brockmeyer DL. Glutaric aciduria type 1 presenting as bilateral subdural hematomas mimicking nonaccidental trauma. Case report and review of the literature. J Neurosurg 2007; 106 (3, suppl) 222-226
    PubMedGoogle Scholar
  • 26 Demailly D, Vianey-Saban C, Acquaviva C. et al. Atypical glutaric aciduria type I with hemidystonia and asymmetric radiological findings misdiagnosed as an Ischemic Stroke. Mov Disord Clin Pract (Hoboken) 2018; 5 (04) 436-438
    CrossrefPubMedGoogle Scholar
  • 27 Kamate M, Patil V, Chetal V, Darak P, Hattiholi V. Glutaric aciduria type I: a treatable neurometabolic disorder. Ann Indian Acad Neurol 2012; 15 (01) 31-34
    CrossrefPubMedGoogle Scholar
  • 28 Vasikarla M, Pandita A, Sharma D, Pratap OT, Murki S. Diagnosis and genetic analysis of glutaric acidaemia type I: very rarely seen inborn error of metabolism. Sultan Qaboos Univ Med J 2015; 15 (04) e572-e573
    CrossrefPubMedGoogle Scholar
  • 29 Goodman SI, Gallegos DA, Pullin CJ. et al. Antenatal diagnosis of glutaric acidemia. Am J Hum Genet 1980; 32 (05) 695-699
    PubMedGoogle Scholar
  • 30 Peng HH, Shaw SW, Huang KG. Prenatal diagnosis of fetal glutaric aciduria type 1 with rare compound heterozygous mutations in GCDH gene. Taiwan J Obstet Gynecol 2018; 57 (01) 137-140
    CrossrefPubMedGoogle Scholar
  • 31 Shaik M, TP KV, Kamate M, AB V. Is Expanded Newborn Screening Adequate to Detect Indian Biochemical Low Excretor Phenotype Patients of Glutaric Aciduria Type I?. Indian J Pediatr 2019; 86 (11) 995-1001
    CrossrefPubMedGoogle Scholar